Anti-CGRP Class Reduces Migraine Burden Regardless of Concomitant Therapies in US Clinical Practice (1301)
Gottschalk P, Henn K, Robinson J, Schobel V. Anti-CGRP Class Reduces Migraine Burden Regardless of Concomitant Therapies in US Clinical Practice (1301). Neurology 2020, 94 DOI: 10.1212/wnl.94.15_supplement.1301.Peer-Reviewed Original Research